Objective To explore the relationship of visceral fat area (VFA) with glucolipid metabolism indexes and insulin resistance (IR) in patients with type 2 diabetes mellitus (T2DM) complicated with obesity. Methods A total of 315 T2DM patients with obesity who were admitted to the hospital from April 2022 to August 2025 were retrospectively selected. The VFA of all patients was measured by bioelectrical impedance analysis method. According to VFA, the patients were classified into VFA≥100 cm² group (n=204) and VFA<100 cm² group (n=111). The glucolipid metabolism indexes [fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), triacylglycerol (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C)] and IR index [homeostasis model assessment of insulin resistance based on C-peptide (HOMA-IR(CP))] were detected and compared between both groups of patients. Spearman correlation method was utilized to analyze the correlation between VFA and glucolipid metabolism indexes and HOMA-IR(CP). The independent related factors of VFA were explored by logistic regression analysis. Results According to VFA results of 315 patients after admission, 204 cases (64.76%) had VFA≥100 cm² and 111 cases (35.24%) had VFA<100 cm². Compared with the VFA<100 cm² group, the FPG, HbA1c, TG, TC, LDL-C and HOMA-IR(CP) in the VFA≥100 cm² group were higher (P<0.05) while the HDL-C was lower (P<0.05). Spearman correlation revealed that VFA≥100 cm² was positively correlated with FPG, HbA1c, TG, TC, LDL-C and HOMA-IR(CP) (P<0.001), and was negatively correlated with HDL-C (P<0.001). After logistic regression analysis, it was found that FPG, TG, HDL-C, HOMA-IR(CP) and body mass index (BMI) were independent related factors of VFA≥100 cm² (P<0.05). Conclusion VFA is closely related to glucolipid metabolism and IR in T2DM patients with obesity. FPG, TG, HDL-C, HOMA-IR(CP) and BMI are independent related factors affecting VFA≥100 cm². However, given the cross-sectional design of this study, the causal timing of this association cannot be determined and needs to be further verified by prospective cohort studies.

Diabetic kidney disease (DKD) is the most common complication of diabetes mellitus (DM). Qianjin Wenwu decoction (QWD), a well-known traditional Korean medicine, has been used for the treatment of DKD, with satisfactory therapeutic effects. This study was designed to investigate the active components and mechanisms of action of QWD in the treatment of DKD. The results demonstrated that a total of 13 active components in five types were found in QWD, including flavonoids, flavonoid glycosides, phenylpropionic acids, saponins, coumarins, and lignins. Two key proteins, TGF-β1 and TIMP-1, were identified as the target proteins through molecular docking. Furthermore, QWD significantly suppressed Scr and BUN levels which increased after unilateral ureteral obstruction (UUO). Hematoxylin & eosin (H&E) and Masson staining results demonstrated that QWD significantly alleviated renal interstitial fibrosis in UUO mice. We also found that QWD promoted ECM degradation by regulating MMP-9/TIMP-1 homeostasis to improve renal tubulointerstitial fibrosis and interfere with the expression and activity of TGF- β1 in DKD treatment. These findings explain the underlying mechanism of QWD for the treatment of DKD, and also provide methodological reference for investigating the mechanism of traditional medicine in the treatment of DKD.
Rats ; Mice ; Animals ; Ureteral Obstruction/metabolism* ; Kidney/metabolism* ; Tissue Inhibitor of Metalloproteinase-1/metabolism* ; Molecular Docking Simulation ; Rats, Sprague-Dawley ; Kidney Diseases/drug therapy* ; Extracellular Matrix/metabolism* ; Flavonoids/metabolism* ; Fibrosis